Pharmaceutical Pricing, Reimbursement and Market Access South East Europe and Turkey Conference 2013

Key Topics

• Critical insights into European trends in public health insurance
• How to develop an effective strategy to succeed in country-specific negotiations for price approval and granting of reimbursement
• How to deal with the increasing complexity and uncertainty in current pricing & reimbursement environment
• Best practices in development of pharmco-economic studies
• Market access an integral part of the company
• Cost-effectiveness measures & the impact on the industry – is the innovation rewarded correctly?
• The role of patient organisations and social networks on increase of patient influence
• Incorporating market access into the entire drug’s life cycle
• Future Challenges in Market Access
• SEE trends in pricing and reimbursement
• P&R Country Reports: Turkey, Romania, Bulgaria, Bosnia and Herzegvina and Croatia
• Take a look at payers perspective

Who should Attend

Vice Presidents, Senior Vice Presidents, Global Heads, Senior Executives, Directors, Heads, Managers and Senior Managers responsible for:

• Market Access
• Pricing & Reimbursement
• Health Economics
• Commercial Pricing and Pricing Strategists
• Regulatory Affairs
• Outcomes Research
• Public Affairs
• Governmental Affairs
• Governmental bodies
• Public Policy Directors
• Regulatory bodies